Preview

Современная ревматология

Расширенный поиск

Поражение осевого с келета при псориатическом артрите

https://doi.org/10.14412/1996-7012-2017-1-46-55

Полный текст:

Аннотация

Поражение позвоночника при псориатическом артрите (ПсА) наблюдается в большом числе случаев, однако до сих пор не сформирован единый подход к решению этой проблемы. Четко не определены критерии диагноза псориатического спондилита, нет общепринятых международных дефиниций для этого понятия, не сформулированы критерии обострения и ремиссии для ПсА с учетом спондилита. У специалистов группы GRAPPA (Group for Research and Assessment of Psoriasis and Psoriatic Arthritis) в настоящее время отсутствуют собственные рекомендации по лечению аксиального поражения при ПсА. В этой области заимствуется терапевтическая тактика, используемая при лечении аксиального спондилоартрита и анкилозирующего спондилита. Поражение позвоночника при ПсА нуждается в дальнейшем изучении.

Об авторах

Е. Е. Губарь
ФГБНУ «Научно-исследовательский институт ревматологии им. В.А. Насоновой»
Россия
115522, Москва, Каширское шоссе, 34А


Е. Ю. Логинова
ФГБНУ «Научно-исследовательский институт ревматологии им. В.А. Насоновой»
Россия
115522, Москва, Каширское шоссе, 34А


Т. В. Коротаева
ФГБНУ «Научно-исследовательский институт ревматологии им. В.А. Насоновой»
Россия
115522, Москва, Каширское шоссе, 34А


Литература

1. Moll JM, Wright V. Psoriatic arthritis. Semin Arthritis Rheum. 1973;3(1):55-78.

2. Hanly J, Russell M, Gladman D. Psoriatic spondyloarthropathy: a long term prospective study. Ann Rheum Dis. 1988 May;47(5):386-93.

3. Lambert J, Wright V. Psoriatic spondylitis: a clinical and radiological description of the spine in psoriatic arthritis. Q J Med. 1977 Oct;46(184):411-25.

4. Battistone M, Manaster B, Reda D, Clegg D. The prevalence of sacroiliitis in psoriatic arthritis: new perspectives from a large multicenter cohort. A Department of Veterans Affair Cooperative Study. Skeletal Radiol. 1999 Apr;28(4):196-201.

5. Jajic I. Radiological changes in the sacro-iliac joints and spine of patients with psoriatic arthritis and psoriasis. Ann Rheum Dis. 1968 Jan;27(1):1-6.

6. Torre Alonso JC, Rodriguez Perez A, Arribas Castrillo JM, et al. Psoriatic arthritis (PA): a clinical, immunological and radiological study of 180 patients. Br J Rheumatol. 1991 Aug;30(4):245-50.

7. Marsal S, Armadans-Gil L, Martinez M, et al. Clinical, radiographic and HLA associations as markers for different patterns of psoriatic arthritis. Rheumatology (Oxford). 1999 Apr;38(4):332-7.

8. De Vlam K, Lories R, Steinfeld S, et al. Is Axial Involvement Underestimated in Patients with Psoriatic Arthritis? Data from the BEPAS Cohort. Ann Rheum Dis. 2016;75:1156-7.

9. Niccoli L, Nannini C, Cassara E, et al. Frequency of iridocyclitis in patients with early psoriatic arthritis: a prospective, follow up study. Int J Rheum Dis. 2012 Aug;15(4): 414-8. doi: 10.1111/j.1756-185X.2012.01736.x. Epub 2012 Apr 29.

10. Gossee L, Smolen JS, Ramiro S. European League Against Rheumatism (EULAR) recommendations for the management of psoriatic arthritis with pharmacological therapies:2015 update. Ann Rheum Dis. 2016 Mar;75(3):499-510. doi: 10.1136/annrheumdis-2015-208337. Epub 2015 Dec 7.

11. Wright V. Psoriatic arthritis. A comparative radiographic study of rheumatoid arthritis and arthritis associated with psoriasis. Ann Rheum Dis. 1961 Jun;20:123-32.

12. Van der Linden S, Valkenburg H, Cats A. Evaluation of diagnostic criteria for ankylosing spondylitis: a proposal for modification of the New York criteria. Arthritis Rheum. 1984 Apr;27(4):361-8.

13. Helliwell PS, Hickling P, Wright V. Do the radiological changes of classic ankylosing spondylitis differ from the changes found in the spondylitis associated with inflammatory bowel disease, psoriasis, and reactive arthritis? Ann Rheum Dis. 1998 Mar;57(3):135-40.

14. Braun J, Rudwaleit M, Kary S, et al. Clinical manifestations and responsiveness to adalimumab are similar in patients with ankylosing spondylitis with and without concomitant psoriasis. Rheumatology (Oxford). 2010 Aug;49(8):1578-89. doi: 10.1093/rheumatology/keq129. Epub 2010 May 6.

15. Nash P, Lubrano E, Cauli A, et al. Updated Guidelines for the Management of Axial Disease in Psoriatic Arthritis. J Rheumatol. 2014 Nov;41(11):2286-9. doi: 10.3899/jrheum.140877.

16. Rudwaleit M, van der Heijde D, Landewe R, et al. The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection. Ann Rheum Dis. 2009 Jun; 68(6):777-83. doi: 10.1136/ard.2009.108233. Epub 2009 Mar 17.

17. Taylor W, Gladman D, Helliwell P, et al. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum. 2006 Aug;54(8):2665-73.

18. Sieper J, Rudwaleit M, Baraliakos X, et al. The Assesment of Spondyloarthritis international Society (ASAS) Handbook: a guide to assess spondyloarthritis. Ann Rheum Dis. 2009 Jun;68 Suppl 2:ii1-44. doi: 10.1136/ard.2008.104018.

19. Chandran V, Tolusso DC, Cook RJ, Gladman DD. Risk factors for axial inflammatory arthritis in patients with psoriatic arthritis. J Rheumatol. 2010 Apr;37(4):809-15. doi: 10.3899/jrheum.091059. Epub 2010 Mar 15.

20. Lubrano E, Marchesoni A, Olivieri I, et al. The radiological assessment of axial involvement in psoriatic arthritis: a validation study of the BASRI total and the modified SASSS scoring methods. Clin Exp Rheumatol. 2009 Nov-Dec;27(6):977-80.

21. Calin A, Porta J, Fries JF, Schurman DJ. Clinical history as a screening test for ankylosing spondylitis. JAMA. 1977 Jun 13; 237(24):2613-4.

22. Sieper J, van der Heijde DM, Landewe R, et al. New criteria for inflammatory back pain in patients with chronic back pain: a real patient exercise by experts from the Assessment of SpondyloArthritis international Society (ASAS). Ann Rheum Dis. 2009 Jun;68(6): 784-8. doi: 10.1136/ard.2008.101501. Epub 2009 Jan 15.

23. Rudwaleit M, Metter A, Listing J, et al. Inflammatory back pain in ankylosing spondylitis: a reassessment of the clinical history for application as classification and diagnostic criteria. Arthritis Rheum. 2006 Feb;54(2):569-78.

24. Mease PJ, Garg A, Helliwell PS, et al. Development of criteria to distinguish inflammatory from noninflammatory arthritis, enthesitis, dactylitis, and spondylitis: a report from the GRAPPA 2013 Annual Meeting. J Rheumatol. 2014 Jun;41(6):1249-51. doi: 10.3899/jrheum.140182.

25. Gladman DD, Brubacher B, Buskila D, et al. Differences in the expression of spondyloarthropaty: A comparison between ankylosing spondylitis and psoriatic arthritis. Clin Invest Med. 1993 Feb;16(1):1-7.

26. Sieper J, Srinivasan S, Zamani O, et al. Comparison of two referral strategies for diagnosis of axial spondyloarthritis: the Recognising and Diagnosing Ankylosing Spondylitis Reliably (RADAR) study. Ann Rheum Dis. 2013 Oct;72(10):1621-7. doi: 10.1136/annrheumdis-2012-201777. Epub 2012 Oct 13.

27. Bonifati C, Elia F, Francesconi F, et al. The diagnosis of early psoriatic arthritis in an outpatient dermatological centre for psoriasis. J Eur Acad Dermatol Venereol. 2012 May;26(5):627-33. doi: 10.1111/j.1468-3083.2011.04138.x. Epub 2011 Jun 4.

28. Queiro R, Alperi M, Lopez A, et al. Clinical expression, but not disease outcome, may vary according to age at disease onset in psoriatic spondylitis. Joint Bone Spine. 2008 Oct;75(5):544-7. doi: 10.1016/j.jbspin.2007.11.005. Epub 2008 May 5.

29. Логинова ЕЮ, Коротаева ТВ, Смирнов АВ и др. Особенности поражения осевого скелета при раннем псориатическом артрите (исследование РЕМАРКА). Научно- практическая ревматология. 2016;54(Прил 1):15-9. [Loginova EYu, Korotaeva TV, Smirnov AV, et al. Specific features of axial skeleton involvement in early psoriatic arthritis (The REMARCA trial). Nauchno-prakticheskaya revmatologiya = Rheumatology Science and Practice. 2016;54(Suppl 1):15-9. (In Russ.)]. doi: 10.14412/1995-4484-2016-1S-15-19.

30. Scarpa R, Oriente P, Pucino A, et al. The clinical spectrum of psoriatic spondylitis. Br J Rheumatol. 1988 Apr;27(2):133-7.

31. Perez Alamino R, Maldonado Cocco JA, Citera G, et al. Differential features between primary ankylosing spondylitis and spondylitis associated with psoriasis and inflammatory bowel disease. J Rheumatol. 2011 Aug;38(8):1656-60. doi: 10.3899/jrheum.101049. Epub 2011 Jun 1.

32. Helliwell PS, Wright V. Psoriatic arthritis: clinical features. In: Klippel JH, Dieppe PA, editors. Rheumatology (Oxford). London: Mosby; 1998.

33. Gladman D, Brubacher B, Buskila D, et al. Psoriatic spondyloarthropathy in men and women: a clinical, radiographic and HLA study. Clin Invest Med. 1992 Aug;15(4):371-5.

34. Queiro R, Belzunegui J, Gonzalez C, et al. Clinically asymptomatic axial disease in psoriatic spondyloarthropathy. A retrospective study. Clin Rheumatol. 2002 Feb;21(1):10-3.

35. Queiro R, Sarasqueta C, Belzunegui J, et al. Psoriatic spondyloarthropathy: a comparative study between HLA-B27 positive and HLA-B27 negative disease. Semin Arthritis Rheum. 2002 Jun;31(6):413-8.

36. Baraliakos X, Coates LC, Braun J. The involvement of the spine in psoriatic arthritis. Clin Exp Rheumatol. 2015 Sep-Oct; 33(5 Suppl 93):S31-5. Epub 2015 Oct 15.

37. Castillo-Gallego C, Aydin SZ, Emery P, et al. Magnetic resonance imaging assessment of axial psoriatic arthritis: extent of disease relates to HLA-B27. Arthritis Rheum. 2013 Sep;65(9):2274-8. doi: 10.1002/art.38050.

38. Queiro R, Sarasqueta C, Torre JC, et al. Comparative analysis of psoriatic spondyloarthropathy between men and women. Rheumatol Int. 2001 Oct;21(2):66-8.

39. McEwen C, Di Tata D, Lingg C, et al. A comparative study of ankylosing spondylitis and spondylitis accompanying ulcerative colitis, regional enteritis, psoriasis and Reiter's disease. Arthritis Rheum. 1971 May-Jun;14(3):291-318.

40. Taylor WJ, Zmierczak HG, Helliwell PS. Problems with the definition of axial and peripheral disease patterns in psoriatic arthritis. J Rheumatol. 2005 Jun;32(6):974-7.

41. Gladman DD: Psoriatic arthritis. Rheum Dis Clin North Am 1998;24:829-44.

42. Gladman DD. Natural history of psoriatic arthritis. Baillieres Clin Rheumatol. 1994 May; 8(2):379-94.

43. Lubrano E, Spadaro A. Unmet needs in outcome measures of Psoriatic Arthritis: focus on axial radiographic and nail involvement. Acta Biomed. 2013 Sep 1;84(2):87-93.

44. Bywaters EG, Dixon AS. Paravertebral ossification in psoriatic arthritis. Ann Rheum Dis. 1965 Jul;24(4):313-31.

45. Ory PA, Gladman DD, Mease PJ. Psoriatic arthritis and imaging. Ann Rheum Dis. 2005 Mar;64 Suppl 2:ii55-7.

46. De Vlam K, Mielants H, Veys EM. Association between ankylosing spondylitis and diffuse idiopathic skeletal hyperostosis: reality or fiction? Clin Exp Rheumatol. 1996 Jan-Feb;14(1):5-8.

47. Jadon DR, Nightingale AL, McHugh NJ, et al. Serum soluble bone turnover biomarkers in psoriatic arthritis and psoriatic spondyloarthropathy. J Rheumatol. 2015 Jan; 42(1):21-30. doi: 10.3899/jrheum.140223. Epub 2014 Nov 1.

48. Fernandez-Sueiro JL. The Challenge and Need of Defining Axial Psoriatic. J Rheumatol. 2009 Dec;36(12):2633-4. doi: 10.3899/jrheum.091023.

49. Blau RH, Kaufman RL. Erosive and subluxing cervical spine disease in patients with psoriatic arthritis. J Rheumatol. 1987 Feb;14(1):111-7.

50. Salvarani C, Macchioni P, Cremonesi T, et al. The cervical spine in patients with psoriatic arthritis: a clinical, radiological and immunogenetic study. Ann Rheum Dis. 1992 Jan;51(1):73-7.

51. Laiho K, Kauppi M. The cervical spine in patients with psoriatic arthritis. Ann Rheum Dis. 2002 Jul;61(7):650-2.

52. Jenkinson T, Armas J, Evison G, et al. The cervical spine in psoriatic arthritis: a clinical and radiological study. Br J Rheumatol. 1994 Mar;33(3):255-9.

53. Killebrew K, Gold RH, Sholkoff SD. Psoriatic spondylitis. Radiology. 1973 Jul; 108(1):9-16.

54. Kaplan D, Plotz CM, Nathanson L, Frank L. Cervical Spine in Psoriasis and in Psoriatic Arthritis. Ann Rheum Dis. 1964 Jan;23:50-6.

55. Neva MH, Kaarela K, Kauppi M. Prevalence of radiological changes in the cervical spine – a cross sectional study after 20 years from presentation of rheumatoid arthritis. J Rheumatol. 2000 Jan;27(1):90-3.

56. Laiho K, Belt E, Kauppi M. The cervical spine in mutilant rheumatoid arthritis. Rheumatol Int. 2001 Aug;20(6):225-8.

57. Suarez-Almazor ME, Russell AS. Anterior atlantoaxial subluxation in patients with spondyloarthropathies: association with peripheral disease. J Rheumatol. 1988 Jun; 15(6):973-5.

58. Lassoued S, Hamidou M, Fournie B, Fournie A. Cervical spine involvement in psoriatic arthritis. J Rheumatol. 1989 Feb; 16(2):251-2.

59. Jeannou J, Goupille P, Avimadje MA, et al. Cervical spine involvement in psoriatic arthritis. Rev Rhum Engl Ed. 1999 Dec;66(12): 695-700.

60. Nash P. Therapies for axial disease in psoriatic arthritis. A systematic review. J Rheumatol. 2006 Jul;33(7):1431-4. Epub 2006 May 15.

61. Baraliakos X, Listing J, von der Recke A, Braun J. The natural course of radiographic progression in ankylosing spondylitisevidence for major individual variations in a large proportion of patients. J Rheumatol. 2009 May;36(5):997-1002. doi: 10.3899/jrheum.080871. Epub 2009 Mar 30.

62. Taylor WJ, Marchesoni A, Arreghini M, et al. A comparison of the performance characteristics of classification criteria for the diagnosis of psoriatic arthritis. Semin Arthritis Rheum. 2004 Dec;34(3):575-84.

63. Almirall M, Salman TC, Lisbona MP, et al. Axial Psoriatic Arthritis with and Without Radiological Involvement: Are There Any Differences? Ann Rheum Dis. 2015;74 (Suppl 2):1173. doi:10.1136/annrheumdis-2015-eular.2319.

64. MacKay K, Mack C, Brophy S, Calin A. The Bath Ankylosing Spondylitis Radiology Index (BASRI): a new, validated approach to disease assessment. Arthritis Rheum. 1998 Dec;41(12):2263-70.

65. Creemers MC, Franssen MJ, van't Hof MA, et al. Assessment Outcome measures in psoriatic arthritis of outcome in ankylosing spondylitis: an extended radiographic scoring system. Ann Rheum Dis. 2005 Jan;64(1): 127-9. Epub 2004 Mar 29.

66. Lubrano E, Marchesoni A, Olivieri I, et al. Psoriatic arthritis spondylitis radiology index: a modified index for radiologic assessment of axial involvement in psoriatic arthritis. J Rheumatol. 2009 May;36(5): 1006-11. doi: 10.3899/jrheum.080491. Epub 2009 Mar 30.

67. Biagoni BJ, Gladman DD, Cook RJ, et al. Reliability of radiographic scoring methods in axial psoriatic arthritis. Arthritis Care Res (Hoboken). 2014 Sep;66(9):1417-22. doi: 10.1002/acr.22308.

68. Braun J, Sieper J, Bollow M. Imaging of sacroiliitis. Clin Rheumatol. 2000;19(1):51-7.

69. Hanly JG, Mitchell MJ, Barnes DC, MacMillan L. Early recognition of sacroiliitis by magnetic resonance imaging and single photon emission computed tomography. J Rheumatol. 1994 Nov;21(11):2088-95.

70. Docherty P, Mitchell MJ, MacMillan L, et al. Magnetic resonance imaging in the detection of sacroiliitis. J Rheumatol. 1992 Mar;19(3):393-401.

71. Braun J, Bollow M, Eggens U, et al. Use of dynamic magnetic resonance imaging with fast imaging in the detection of early and advanced sacroiliitis in spondylarthropathy patients. Arthritis Rheum. 1994;37:1039-45

72. Braun J, Braun M, Sieper J. Radiologic diagnosis and pathology of the spondyloarthropathies. Rheum Dis Clin North Am. 1998 Nov;24(4):697-735.

73. Williamson L, Dockerty JL, Dalbeth N, et al. Clinical assessment of sacroiliitis and HLA- B27 are poor predictors of sacroiliitis diagnosed by magnetic resonance imaging in psoriatic arthritis. Rheumatology (Oxford). 2004 Jan;43(1):85-8. Epub 2003 Sep 16.

74. Gladman DD. Inflammatory spinal disease in psoriatic arthritis: a report from the GRAPPA 2010 annual meeting. J Rheumatol. 2012 Feb;39(2):418-20. doi:

75. 3899/jrheum.111238.

76. Eder L, Chandran V, Shen H, et al. Is ASDAS better than BASDAI as a measure of disease activity in axial psoriatic arthritis? Ann Rheum Dis. 2010 Dec;69(12):2160-4. doi: 10.1136/ard.2010.129726. Epub 2010 Jul 13.

77. Van der Heijde D, Lie E, Kvien TK, Sieper J; Assessment of SpondyloArthritis international Society (ASAS). ASDAS, a highly discriminatory ASAS-endorsed disease activity score in patients with ankylosing spondylitis. Ann Rheum Dis. 2009 Dec;68(12):1811-8. doi: 10.1136/ard.2008.100826. Epub 2008 Dec 5.

78. Mumtaz A, Gallagher P, Kirby B, et al. Development of a preliminary composite disease activity index in psoriatic arthritis. Ann Rheum Dis. 2011 Feb;70(2):272-7. doi: 10.1136/ard.2010.129379. Epub 2010 Nov 29.

79. Корсакова ЮЛ. Псориаз и псориатический артрит: актуальные вопросы. Современная ревматология. 2012;6(3):28-32. [Korsakova YuL. Psoriasis and psoriatic arthritis: Topical issues. Sovremennaya revmatologiya = Modern Rheumatology Journal. 2012;6(3):28-32. (In Russ.)]. doi: 10.14412/1996-7012-2012-742.

80. Poddubnyy D, Rudwaleit M, Haibel H, et al. Effect of non-steroidal anti-inflammatory drugs on radiographic spinal progression in patients with axial spondyloarthritis: Results from the German Spondyloarthritis Inception Cohort. Ann Rheum Dis. 2012 Oct;71(10):1616-22. doi: 10.1136/annrheumdis-2011-201252. Epub 2012 Mar 29.

81. Haroon N, Kim TH, Inman RD. NSAIDs and radiographic progression in ankylosing spondylitis: Bagging big game with small arms? Ann Rheum Dis. 2012 Oct;71(10):1593-5. doi: 10.1136/annrheumdis-2012-201844. Epub 2012 Aug 3.

82. Lubrano E, Spadaro A, Marchesoni A, et al. The effectiveness of a biologic agent on axial manifestations of psoriatic arthritis. A twelve months observational study in a group of patients treated with etanercept. Clin Exp Rheumatol. 2011 Jan-Feb;29(1):80-4. Epub 2011 Feb 23.

83. Kavanaugh A, McInnes I, Mease P, et al. Golimumab, a new human tumor necrosis factor alpha antibody, administered every four weeks as a subcutaneous injection in psoriatic arthritis: Twenty-four-week efficacy and safety results of a randomized, placebocontrolle study. Arthritis Rheum. 2009 Apr; 60(4):976-86. doi: 10.1002/art.24403.

84. Van der Heijde D, Fleischmann R, Wollenhaupt J, et al. Effect of different imputation approaches on the evaluation of radiographic progression in patients with psoriatic arthritis: Results of the RAPID-PsA 24-week phase III double-blind randomised placebo- controlled study of certolizumab pegol. Ann Rheum Dis. 2014 Jan;73(1):233-7. doi: 10.1136/annrheumdis-2013-203697. Epub 2013 Aug 13.

85. Inman RD, Davis JC Jr, van der Heijde D, et al. Efficacy and safety of golimumab in patients with nkylosing spondylitis: Results of a randomized, double-blind, placebo- controlled, phase III trial. Arthritis Rheum. 2008 Nov;58(11):3402-12. doi: 10.1002/art.23969.

86. Sieper J, van der Heijde D, Dougados M, et al. Efficacy and safety of adalimumab in patients with non-radiographic axia spondyloarthritis: Results of a randomised placebo- controlled trial (ABILITY-1). Ann Rheum Dis. 2013 Jun;72(6):815-22. doi: 10.1136/annrheumdis-2012-201766. Epub 2012 Jul 7.

87. Fagerli KM, Lie E, van der Heijde D, et al. The role of methotrexate co-medication in TNF- inhibitor treatment in patients with psoriatic arthritis: Results from 440 patients included in the NOR-DMARD study. Ann Rheum Dis. 2014 Jan;73(1):132-7. doi: 10.1136/annrheumdis- 2012-202347. Epub 2013 Jan 3.

88. Behrens F, Koehm M, Arndt U, et al. Does Concomitant Methotrexate with Adalimumab Influence Treatment Outcomes in Patients with Psoriatic Arthritis? Data from a Large Observational Study. J Rheumatol. 2016 Mar;43(3):632-9. doi: 10.3899/jrheum.141596. Epub 2015 Dec 15.

89. Kingsley GH, Kowalczyk A, Taylor H, et al. A randomized placebo-controlled trial of methotrexate in psoriatic arthritis. Rheumatology (Oxford). 2012 Aug;51(8): 1368-77. doi: 10.1093/rheumatology/kes001. Epub 2012 Feb 17.

90. Vogelzang EH, Kneepkens EL, Nurmohamed MT, et al. Anti-adalimumab antibodies and adalimumab concentrations in psoriatic arthritis; an association with disease activity at 28 and 52 weeks of follow-up. Ann Rheum Dis. 2014 Dec;73(12):2178-82. doi: 10.1136/annrheumdis-2014-205554. Epub 2014 Aug 12.

91. Vogelzang EH, Pouw MF, Nurmohamed M, et al. Adalimumab trough concentrations in patients with rheumatoid arthritis and psoriatic arthritis treated with concomitant disease- modifying antirheumatic drugs. Ann Rheum Dis. 2015 Feb;74(2): 474-5. doi: 10.1136/annrheumdis-2014-206588. Epub 2014 Nov 28.

92. Kristensen LE, Gü lfe A, Saxne T, Geborek P. Efficacy and tolerability of antitumour necrosis factor therapy in psoriatic arthritis patients: results from the South Swedish Arthritis Treatment Group register. Ann Rheum Dis. 2008 Mar;67(3):364-9. Epub 2007 Jul 20.

93. Mease PJ, Genovese MC, Greenwald MW, et al. Brodalumab, an anti-IL17RA monoclonal antibody, in psoriatic arthritis. N Engl J Med. 2014 Jun 12;370(24):2295-306. doi: 10.1056/NEJMoa1315231.

94. McInnes IB, Kavanaugh A, Gottlieb AB, et al. Efficacy and safety of ustekinumab in patients with active psoriatic arthritis: 1 year results of the phase 3, multicentre, doubleblind, placebo-controlled PSUMMIT 1 trial. Lancet. 2013 Aug 31;382(9894):780-9. doi: 10.1016/S0140-6736(13)60594-2. Epub 2013 Jun 13.

95. Kavanaugh A, Puig L, Gottlieb AB, et al. Efficacy and safety of ustekinumab in psoriatic arthritis patients with peripheral arthritis and physician-reported spondylitis: post-hoc analyses from two phase III, multicentre, double-blind, placebo-controlled studies (PSUMMIT-1/PSUMMIT-2). Ann Rheum Dis. 2016 Nov;75(11):1984-1988. doi: 10.1136/annrheumdis-2015-209068. Epub 2016 Apr 20.

96. Baeten D, Sieper J, Braun J, et al. MEASURE 1 and MEASURE 2 Study Groups Secukinumab, an Interleukin-17A Inhibitor, in Ankylosing Spondylitis. N Engl J Med. 2015 Dec 24;373(26):2534-48. doi: 10.1056/NEJMoa1505066.

97. McInnes IB, Sieper J, Braun J, et al. Efficacy and safety of secukinumab, a fully human anti-interleukin-17A monoclonal antibody, in patients with moderate-to-severe psoriatic arthritis: A 24-week, randomised, double-blind, placebo-controlled, phase II proof-of- concept trial. Ann Rheum Dis. 2014 Feb;73(2):349-56. doi: 10.1136/annrheumdis-2012-202646. Epub 2013 Jan 29.

98. Schett G, Wollenhaupt J, Papp K, et al. Oral apremilast in the treatment of active psoriatic arthritis: Results of a multicenter, randomized, double-blind, placebocontrolled study. Arthritis Rheum. 2012 Oct;64(10):3156-67. doi: 10.1002/art.34627.

99. Rudwaleit M, van der Heijde D, Landewe R, et al. The Assessment of SpondyloArthritis international Society classification criteria for peripheral spondyloarthritis and for spondyloarthritis in general. Ann Rheum Dis. 2011;70:25-31.


Для цитирования:


Губарь Е.Е., Логинова Е.Ю., Коротаева Т.В. Поражение осевого с келета при псориатическом артрите. Современная ревматология. 2017;11(1):46-55. https://doi.org/10.14412/1996-7012-2017-1-46-55

For citation:


Gubar E.E., Loginova E.Y., Korotaeva T.V. Involvement of the axial skeleton in psoriatic arthritis. Modern Rheumatology Journal. 2017;11(1):46-55. (In Russ.) https://doi.org/10.14412/1996-7012-2017-1-46-55

Просмотров: 163


Creative Commons License
Контент доступен под лицензией Creative Commons Attribution 4.0 License.


ISSN 1996-7012 (Print)
ISSN 2310-158X (Online)